SIMCERE PHARMAC. GRP LTD Capital Reinvestment Ratio
SIMCERE PHARMAC. GRP LTD capital reinvestment ratio. SIMCERE PHARMAC. GRP LTD (S2P) has a Capital Reinvestment Ratio of 0.43x as of December 2025, meaning it reinvests 0% of its operating cash flow (€2.01 Billion) in capital expenditures (€862.20 Million). Check SIMCERE PHARMAC. GRP LTD (S2P) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SIMCERE PHARMAC. GRP LTD (2022–2025)
Capital reinvestment ratio of SIMCERE PHARMAC. GRP LTD from 2022 to 2025. This chart tracks SIMCERE PHARMAC. GRP LTD's Capital Reinvestment Ratio across 4 annual periods. Also explore SIMCERE PHARMAC. GRP LTD annual equity growth to track the company's year-over-year net asset growth rate.
SIMCERE PHARMAC. GRP LTD Capital Reinvestment Ratio by Year (2022–2025)
SIMCERE PHARMAC. GRP LTD capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see SIMCERE PHARMAC. GRP LTD operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | €2.01 Billion | €862.20 Million | ▼ -21.9% |
| 2024 | 0.55x | €1.39 Billion | €762.57 Million | ▼ -91.5% |
| 2023 | 6.49x | €151.05 Million | €979.86 Million | ▲ +1195.6% |
| 2022 | 0.50x | €1.35 Billion | €678.00 Million | — |